Two cohorts of mice, including bitransgenic mCre-CM(+) mice that carried the CRTC1-MAML2 transgene and age-matched transgene-negative mCre-CM(–) littermate controls, were obtained and monitored for tumor development. Here, MAML2 is linked to neoplasm.